Phase 1 Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to give their consent to participate after being fully informed about the trial.
- People who are in good general and mental health, without any ongoing significant medical concerns in their medical history.
- People who have been diagnosed with open-angle glaucoma or high eye pressure (ocular hypertension), and also have an age-related cataract that is suitable for a standard lens implant during cataract surgery.
- People who have had a successful cataract surgery without complications.
Who may not be able to join:
- People who have a history of allergic reactions or medical reasons preventing them from taking beta-blocker medications (a type of drug used to treat conditions like glaucoma and high blood pressure).
- People who are currently using any medication — whether taken by mouth or applied to the eye — that is known to affect vision, pupil size, or the structure of the iris (the coloured part of the eye).
- People for whom stopping their current eye pressure-lowering medications would carry significant health risks.
- People who have other significant eye conditions beyond high eye pressure, glaucoma, or cataracts.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +3242299000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number (%) of participants experiencing adverse events; Number (%) of participants experiencing adverse events of special interest (AESI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.